Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
Kristin L. White(Dartmouth College), Ursula Eilber(University of Helsinki), Yukie T. Bean(Oregon Health & Science University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Peter A. Fasching(Universitätsklinikum Erlangen), Claus Høgdall(Copenhagen University Hospital), Jenny Chang‐Claude(Universität Hamburg), Florian Heitz(Kliniken Essen-Mitte), Robert A. Vierkant(Mayo Clinic), James M. Flanagan(QIMR Berghofer Medical Research Institute), Estrid Høgdall(University of Copenhagen), James Paul(Cancer Research UK), Douglas A. Levine(New York University), Susanne K. Kjær(Copenhagen University Hospital), Ian Campbell(The University of Sydney), Marc T. Goodman(Cedars-Sinai Medical Center), Alice S. Whittemore(Cancer Registry of Norway), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Bridget Charbonneau(Cedars-Sinai Medical Center), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Andreas du Bois(Kliniken Essen-Mitte), Lene Lundvall(University of Copenhagen), Robert Brown(Emerson College), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Daniel W. Cramer(Brigham and Women's Hospital), Nicolas Wentzensen(National Cancer Institute), Joellen M. Schildkraut(Duke University Hospital), Irene Orlow(Memorial Sloan Kettering Cancer Center), Tanja Pejović(Oregon Health & Science University), Lisa E. Paddock(Rutgers, The State University of New Jersey), Jolanta Kupryjańczyk(Cedars-Sinai Medical Center), Hoda Anton Culver(University of California, Irvine), Anja Rudolph(Institut für Qualität im Management (Germany)), Philipp Harter(Kliniken Essen-Mitte), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Usha Menon(University of South Florida), Beth Y. Karlan(University of California, Los Angeles), Alexander Hein, Paul D.P. Pharoah(Cedars-Sinai Medical Center), Ira Schwaab(Cancer Institute of New South Wales), Jacek Gronwald(International Hereditary Cancer Center), Galina Lurie(Cancer Prevention Institute of California), Celeste Leigh Pearce(University of Southern California), Mary Anne Rossing(Fred Hutch Cancer Center), Stanley B. Kaye(Royal Marsden Hospital), Matthew S. Block(Mayo Clinic in Arizona), Diana Eccles(Princess Anne Hospital), Zachary C. Fogarty(Mayo Clinic in Florida)
Cited by 23
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k